Binding and detoxification efficiency of albumin decline after haemodialysis.

Publication Year: 2024

DOI:
10.1093/ndt/gfad133

PMCID:
PMC10828194

PMID:
37558390

Journal Information

Full Title: Nephrol Dial Transplant

Abbreviation: Nephrol Dial Transplant

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Transplantation

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT K.O. has received the Albus Award by Grifols SA, Spain and is consultant of Takeda Pharmaceuticals International AG. M.P. has received the Albus Award by Grifols SA, Spain. A.K. has received grants for clinical studies, speaker's fees, honoraria and travel expenses from Actelion, Amgen, Amicus, Alexion, Astellas, Bayer, Baxter, Binding Site, Bristol Myers, Chiesi, CytoSorbents, Fresenius, GlaxoSmithKline, Hexal, Janssen, Kyowa Kirin, MSD, Novartis, Otsuka, Peripal, Pfizer, Roche, Sanofi, Shire, Teva and Vifor Fresenius Medical. All other authors declare no conflict of interests."

Evidence found in paper:

"FUNDING This research received external funding from Stiftung Universitätsmedizin Essen (2022 4699 112)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025